2019 Yellow Fever Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 62 pages | ID: 2403AB8A1C5EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Yellow Fever Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Yellow Fever. It presents in-depth analysis of Yellow Fever clinical trials across markets and companies. The research work is for providing complete understanding into trends in Yellow Fever.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Yellow Fever clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Yellow Fever

The research work is prepared through extensive and continuous research on Yellow Fever trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Yellow Fever patients are identified
• The report includes panorama of Yellow Fever clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Yellow Fever clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Yellow Fever Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Yellow Fever Clinical Trials by Region
  2.2.2 Average Enrollment of Yellow Fever Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Yellow Fever Treatment, 2019

3. REGION WISE YELLOW FEVER CLINICAL TRIALS

3.1 Asia Pacific Yellow Fever Clinical Trials by Country
3.2 Europe Yellow Fever Clinical Trials by Country
3.3 North America Yellow Fever Clinical Trials by Country
3.4 Middle East and Africa Yellow Fever Clinical Trials by Country
3.5 South and Central America Yellow Fever Clinical Trials by Country

4. YELLOW FEVER CLINICAL TRIAL TRENDS

4.1 Start Year wise Yellow Fever Clinical Trials
4.2 Phase wise Yellow Fever Clinical Trials
4.3 Trial Status wise Yellow Fever Clinical Trials
4.4 Trial Type wise Yellow Fever Clinical Trials

5. YELLOW FEVER AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Yellow Fever Trials by Year
5.2 Average Enrollment in Yellow Fever Trials by Phase
5.3 Average Enrollment in Yellow Fever Trials by Status
5.4 Average Enrollment in Yellow Fever Trials by Type of Trial

6. COMPANIES PARTICIPATING IN YELLOW FEVER CLINICAL TRIALS

6.1 Yellow Fever Trials by Sponsor Type
6.2 Yellow Fever Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Yellow Fever Trials- Phase
7.2 Yellow Fever Trials- Phase
7.3 Yellow Fever Trials- Phase
7.4 Yellow Fever Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Yellow Fever Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Yellow Fever Clinical Trials and Enrolment
Figure 5: Europe – Country wise Yellow Fever Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Yellow Fever Clinical Trials and Enrolment
Figure 7: North America – Country wise Yellow Fever Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Yellow Fever Clinical Trials and Enrolment
Figure 9: Yellow Fever Clinical Trials by Phase
Figure 10: Yellow Fever Clinical Trials by Trial Status
Figure 11: Yellow Fever Clinical Trials by Type
Figure 12: Yellow Fever Clinical Trials by Sponsor Type
Figure 13: Yellow Fever Clinical Trials by Leading Sponsors
Figure 14: Yellow Fever Average Enrollment by Phase
Figure 15: Yellow Fever Average Enrollment by Trial Status
Figure 16: Yellow Fever Average Enrollment by Type
Figure 17: Yellow Fever- Average Enrolment by Type of Sponsors
Figure 18: Yellow Fever- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Yellow Fever Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Yellow Fever Clinical Trials and Enrolment
Table 5: Europe – Country wise Yellow Fever Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Yellow Fever Clinical Trials and Enrolment
Table 7: North America – Country wise Yellow Fever Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Yellow Fever Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Yellow Fever Average Enrollment by Phase
Table 15: Yellow Fever Average Enrollment by Trial Status
Table 16: Yellow Fever Average Enrollment by Type
Table 17: Yellow Fever- Average Enrolment by Type of Sponsors
Table 18: Yellow Fever- Enrolment by Leading Sponsors